Fig. 3From: Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancerDisease-free survival according to the ICR classification in NSCLC untreated with ICI. Kaplan–Meier DFS curves in early-stage patients with lung adenocarcinoma and squamous cell carcinoma (TCGA dataset) according to the two ICR classes (ICR1 versus ICR2-4). The p-value indicated is for the log-rank testBack to article page